Grow your business safely with MA PHARMACIE TALENCE PAUL LAPIE

All the information you need about MA PHARMACIE TALENCE PAUL LAPIE to develop and secure your business in France

M HOME > CORPORATES > MA PHARMACIE TALENCE PAUL LAPIE > BALANCE SHEET ( 2023-04-20)

THE LIST OF BALANCE SHEET : MA PHARMACIE TALENCE PAUL LAPIE

CORPORATEBOBACCESTABLISHMENTSMANAGERSFINANCE
Deposit Confidentiality closing date document
2023-04-20 Partially confidential 2020-09-30 Complete
2022-05-16 Partially confidential 2021-09-30 Complete
NameMA PHARMACIE TALENCE PAUL LAPIE
Siren842638033
Closing2020-09-30
Registry code 3302
Registration number 6755
Management number2018D02043
Activity code 4773Z
Closing date n-12019-09-30
Duration Fiscal year 12
Duration Fiscal year n-112
Filing date2023-04-20
Modification00 Annual accounts entered without anomaly
Balance sheet typeC : Complete
Currency codeEUR
ConfidentialityPartially confidential
Address33400 Talence
1 - Assets (balance sheet)Gross amount year NAmortization year NNet year NNet year N-1
AH Goodwill 255 000.00 255 000.00 255 000.00
AT Other tangible assets 7 000.00 5 542.00 1 458.00 7 000.00
BJ TOTAL (I) 262 015.00 5 542.00 256 473.00 262 015.00
BT Goods 78 624.00 1 675.00 76 949.00 78 624.00
BX Customers and related accounts 9 659.00 9 659.00 9 659.00
BZ Other receivables 10 650.00 10 650.00 10 650.00
CF Cash and cash equivalents 63 776.00 63 776.00 63 776.00
CH Prepaid expenses 654.00 654.00 654.00
CJ TOTAL (II) 163 364.00 1 675.00 161 689.00 163 364.00
CO Grand total (0 to V) 425 379.00 7 218.00 418 162.00 425 379.00
CU Other investments 15.00 15.00 15.00
2 - Liabilities (balance sheet)Amount year NAmount year N-1
DA Share or individual capital 30 000.00 30 000.00
DD Legal reserve (1) 2 530.00 2 530.00
DG Other reserves 48 076.00 48 076.00
DI RESULTS FOR THE YEAR (Profit or Loss) 37 783.00 37 783.00
DL TOTAL (I) 118 390.00 118 390.00
DU Loans and Debts from Credit Institutions (3) 220 604.00 220 604.00
DX Trade payables and related accounts 60 087.00 60 087.00
DY Tax and social security liabilities 16 705.00 16 705.00
EA Other liabilities 2 376.00 2 376.00
EC TOTAL (IV) 299 772.00 299 772.00
EE Grand total (I to V) 418 162.00 418 162.00
EG Accrued income and payables due within one year 100 156.00 100 156.00
5 - Fixed assets increase - decreaseGross value at beginning of year - Item by itemRevaluation - DisposalsAcquisition - Gross value at year-end
0G ACQUISITIONS Total General Total 262 015.00 262 015.00
I3 DECREASES Total Financial Fixed Assets 15.00
I4 DECREASES Grand Total 262 015.00
IO DECREASES Total including other intangible assets 255 000.00
IY DECREASES Total Tangible Fixed Assets 7 000.00
KD ACQUISITIONS Total including other intangible assets 255 000.00 255 000.00
LN ACQUISITIONS Total Tangible Fixed Assets 7 000.00 7 000.00
LQ ACQUISITIONS Total Financial Fixed Assets 15.00 15.00
6 - Depreciation Amount at beginning of yearIncrease: allocation for the yearDiminution repriseYear-end amount
0N DEPRECIATION Grand Total 5 142.00 400.00 5 142.00
QU DEPRECIATION Total Tangible Fixed Assets 5 142.00 400.00 5 142.00
7 - Provisions Amount at beginning of yearIncrease: allocation for the yearDiminution repriseYear-end amount
6N Inventories and work in progress 957.00 1 675.00 957.00 957.00
7B Total provisions for depreciation 957.00 1 675.00 957.00 957.00
7C Grand total 957.00 1 675.00 957.00 957.00
8 - Receivables and payablesGross amountAmount within 1 yearAmount 1 to 5 yearsAmount more than 5 years
8B Suppliers and Related Accounts 60 087.00 60 087.00 60 087.00
8D Social Security and Other Social Organizations 16 705.00 16 705.00 16 705.00
8K Other liabilities (including liabilities related to repo transactions) 2 376.00 2 376.00 2 376.00
VG Loans with a maturity of up to one year at origin 220 604.00 20 988.00 85 698.00 220 604.00
VS Prepaid expenses 20 964.00 20 964.00 20 964.00
VT TOTAL – STATEMENT OF RECEIVABLES 20 964.00 20 964.00 20 964.00
VY TOTAL – STATEMENT OF LIABILITIES 299 772.00 100 156.00 85 698.00 299 772.00

all companies in France

Complete and comprehensive database.